Diabetes

Showing NaN - NaN of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • basal insulin
  • Birmingham, Alabama
  • +57 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +85 more
May 28, 2019

Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes Trial in Worldwide (ALN-PCSSC, Normal Saline)

Completed
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Jacksonville, Florida
  • +53 more
Apr 23, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Birmingham, Alabama
  • +98 more
Dec 7, 2018

Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 1
  • inhaled human insulin
  • +2 more
  • Birmingham, Alabama
  • +95 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Obesity, Diabetes, Hypertension Trial in Birmingham (Exercise, Reduced Calorie Diet, Weight Maintenance Diet)

Completed
  • Obesity
  • +3 more
  • Exercise
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 1, 2017

Diabetes, Pre-hypertension, Hypertension Trial in Birmingham (aliskiren 300 mg once daily, Placebo/sugar pill)

Terminated
  • Diabetes
  • +2 more
  • aliskiren 300 mg once daily
  • Placebo/sugar pill
  • Birmingham, Alabama
    UAB
Apr 5, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Dietary regimen)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin detemir
  • Dietary regimen
  • Birmingham, Alabama
  • +111 more
Mar 28, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Alexander City, Alabama
  • +135 more
Mar 8, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Birmingham, Alabama
  • +90 more
Mar 8, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin NPH, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Pleven, Bulgaria
  • +42 more
Jan 30, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, NPH insulin, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Buenos Aires, Argentina
  • +99 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Ireland, United Kingdom (biphasic insulin aspart, insulin detemir, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +2 more
  • Dublin, Ireland
  • +62 more
Jan 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, exenatide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +125 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +165 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, insulin detemir, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alexander City, Alabama
  • +232 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • Birmingham, Alabama
  • +44 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +104 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Northridge, California
  • +98 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ebreichsdorf, Austria
  • +73 more
Feb 28, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin aspart
  • insulin detemir
  • Birmingham, Alabama
  • +66 more
Jan 2, 2017